• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寡肽 I-C-F-6 通过抑制 NF-κB 信号通路和 Wnt/β-catenin 信号通路抑制肝星状细胞活化,改善 CCl4 诱导的肝纤维化。

Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling.

机构信息

School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.

Traditional Chinese Medicine Department of No. 458 Hospital of PLA, Guangdong 510602, China.

出版信息

J Pharmacol Sci. 2018 Mar;136(3):133-141. doi: 10.1016/j.jphs.2018.01.003. Epub 2018 Feb 2.

DOI:10.1016/j.jphs.2018.01.003
PMID:29501581
Abstract

Oligo-peptide I-C-F-6 is a Carapax trionycis extract component that has an effect on hepatic fibrosis, however, its mechanism of action is still unclear. This study investigated whether oligo-peptide I-C-F-6 could inhibit liver fibrosis by suppressing NF-κB and Wnt/β-catenin signaling, which are important in liver fibrosis. HSC-T6 cells were treated with oligo-peptide I-C-F-6, and rats were divided randomly into five groups: control (saline), CCl, CCl plus oligo-peptide I-C-F-6 (0.12 and 0.24 mg/kg), and CCl plus colchicine (0.11 mg/kg). Here, we demonstrated that oligo-peptide I-C-F-6 ameliorated liver injury, inflammation, and hepatic fibrogenesis induced by CCl. Oligo-peptide I-C-F-6 also inhibited the activation of hepatic stellate cells (HSCs) in vivo and in vitro, as evaluated by the expression of transforming growth factor-β1 (TGF-β1) and α-smooth muscle actin (α-SMA), which is a specific marker of HSC activation. Moreover, oligo-peptide I-C-F-6 significantly reduced the expression and distribution of β-catenin, P-AKT, phospho (P)-GSK-3β, nuclear factor κB (NF-κB) P65, phospho-P65, and IκB kinase α/β (IKK-α/β) levels; additionally, IκB-α level was elevated both in vivo and in vitro. Together, these results indicate that oligo-peptide I-C-F-6 has hepatoprotective and anti-fibrotic effects in animal models of liver fibrosis, the mechanism of which may be related to modulating NF-κB and Wnt/β-catenin signaling.

摘要

寡肽 I-C-F-6 是一种龟板提取物成分,对肝纤维化有影响,但作用机制尚不清楚。本研究探讨了寡肽 I-C-F-6 是否通过抑制 NF-κB 和 Wnt/β-catenin 信号通路来抑制肝纤维化,这两个信号通路在肝纤维化中非常重要。用寡肽 I-C-F-6 处理 HSC-T6 细胞,将大鼠随机分为五组:对照组(生理盐水)、CCl4 组、CCl4 加寡肽 I-C-F-6(0.12 和 0.24 mg/kg)组和 CCl4 加秋水仙碱(0.11 mg/kg)组。结果表明,寡肽 I-C-F-6 可改善 CCl4 诱导的肝损伤、炎症和肝纤维化。寡肽 I-C-F-6 还抑制了体内和体外肝星状细胞(HSCs)的活化,通过转化生长因子-β1(TGF-β1)和α-平滑肌肌动蛋白(α-SMA)的表达来评估,这是 HSCs 活化的特异性标志物。此外,寡肽 I-C-F-6 显著降低了β-catenin、P-AKT、磷酸化(P)-GSK-3β、核因子κB(NF-κB)P65、磷酸化 P65 和 IKK-α/β(IKK-α/β)的表达和分布;此外,IκB-α 水平在体内和体外均升高。综上所述,这些结果表明,寡肽 I-C-F-6 对肝纤维化动物模型具有保肝和抗纤维化作用,其机制可能与调节 NF-κB 和 Wnt/β-catenin 信号通路有关。

相似文献

1
Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling.寡肽 I-C-F-6 通过抑制 NF-κB 信号通路和 Wnt/β-catenin 信号通路抑制肝星状细胞活化,改善 CCl4 诱导的肝纤维化。
J Pharmacol Sci. 2018 Mar;136(3):133-141. doi: 10.1016/j.jphs.2018.01.003. Epub 2018 Feb 2.
2
DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl-induced liver fibrosis by suppressing Wnt/β-catenin signaling.DCDC2通过抑制Wnt/β-连环蛋白信号通路抑制肝星状细胞活化并改善四氯化碳诱导的肝纤维化。
Sci Rep. 2024 Apr 24;14(1):9425. doi: 10.1038/s41598-024-59698-w.
3
Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.夏雨血汤(XYXD)通过靶向NF-κB和TGF-β1信号通路抑制肝星状细胞活化,减轻四氯化碳(CCl4)诱导的肝纤维化。
BMC Complement Altern Med. 2015 Jun 30;15:201. doi: 10.1186/s12906-015-0733-1.
4
Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-β1/Smad and NFκB signaling.龟甲提取物通过 TGF-β1/Smad 和 NFκB 信号通路抑制活化的肝星状细胞的纤维化。
Biomed Pharmacother. 2017 Nov;95:11-17. doi: 10.1016/j.biopha.2017.08.011. Epub 2017 Aug 18.
5
Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways.槲皮素通过调节HMGB1-TLR2/4-NF-κB信号通路减轻小鼠肝星状细胞的激活和肝纤维化。
Toxicol Lett. 2016 Nov 2;261:1-12. doi: 10.1016/j.toxlet.2016.09.002. Epub 2016 Sep 4.
6
Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.奥曲肽通过抑制 Wnt/β-catenin 信号通路、c-Myc 和细胞周期蛋白 D1 来减轻肝纤维化和肝星状细胞增殖及活化。
Int Immunopharmacol. 2018 Oct;63:183-190. doi: 10.1016/j.intimp.2018.08.005. Epub 2018 Aug 8.
7
Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.六味五灵片通过调节 TGF-β/Smad 和 NF-κB 信号通路减轻 BDL 诱导的肝纤维化。
J Ethnopharmacol. 2018 Jan 10;210:232-241. doi: 10.1016/j.jep.2017.08.029. Epub 2017 Aug 31.
8
Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.岩白菜素 D 通过阻断 TGF-β/Smad 和 YAP 信号通路抑制肝星状细胞激活和肝纤维化。
Phytomedicine. 2020 Nov;78:153294. doi: 10.1016/j.phymed.2020.153294. Epub 2020 Jul 28.
9
Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway.NLRC5 通过调控核因子-κB 信号通路对肝星状细胞的激活和逆转作用。
World J Gastroenterol. 2019 Jun 28;25(24):3044-3055. doi: 10.3748/wjg.v25.i24.3044.
10
Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.片仔癀通过抑制 NF-κB 通路和促进 HSC 凋亡来改善肝纤维化。
J Ethnopharmacol. 2019 Nov 15;244:111856. doi: 10.1016/j.jep.2019.111856. Epub 2019 Apr 5.

引用本文的文献

1
A network pharmacology approach confirms Biejiaxiaozheng pills combat hepatic fibrosis by modulating macrophage inflammation and hepatic stellate cell activation.一种网络药理学方法证实,鳖甲消症丸通过调节巨噬细胞炎症和肝星状细胞激活来对抗肝纤维化。
Sci Rep. 2025 Jul 9;15(1):24638. doi: 10.1038/s41598-025-09002-1.
2
Recent Advances in Therapeutic Peptides: Innovations and Applications in Treating Infections and Diseases.治疗性肽的最新进展:在治疗感染和疾病中的创新与应用
ACS Omega. 2025 Apr 23;10(17):17087-17107. doi: 10.1021/acsomega.5c02077. eCollection 2025 May 6.
3
I-C-F-6 attenuates chronic cerebral hypoperfusion-induced neurological injury in mice by modulating microglia polarization.
I-C-F-6通过调节小胶质细胞极化减轻小鼠慢性脑灌注不足诱导的神经损伤。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3917-3928. doi: 10.1007/s00210-023-02783-0. Epub 2023 Nov 21.
4
Matrine improves the hepatic microenvironment and reverses epithelial-mesenchymal transition in hepatocellular carcinoma by inhibiting the Wnt-1/β-catenin signaling pathway.苦参碱通过抑制Wnt-1/β-连环蛋白信号通路改善肝细胞癌的肝微环境并逆转上皮-间质转化。
Am J Transl Res. 2023 Aug 15;15(8):5047-5070. eCollection 2023.
5
Treatment of Liver Fibrosis after Hepatitis B with TCM Combined with NAs Evaluated by Noninvasive Diagnostic Methods: A Retrospective Study.采用非侵入性诊断方法评估中医药联合核苷(酸)类似物治疗乙型肝炎后肝纤维化:一项回顾性研究
Evid Based Complement Alternat Med. 2023 Apr 25;2023:5711151. doi: 10.1155/2023/5711151. eCollection 2023.
6
Zinc oxide nanoparticles and spironolactone-enhanced Nrf2/HO-1 pathway and inhibited Wnt/β-catenin pathway in adenine-induced nephrotoxicity in rats.氧化锌纳米粒子和螺内酯增强 Nrf2/HO-1 通路并抑制腺嘌呤诱导的大鼠肾毒性中的 Wnt/β- 连环蛋白通路。
Redox Rep. 2022 Dec;27(1):249-258. doi: 10.1080/13510002.2022.2139947.
7
Cellular signaling crosstalk between Wnt signaling and gap junctions inbenzo[a]pyrene toxicity.苯并[a]芘毒性中Wnt信号通路与缝隙连接之间的细胞信号串扰。
Cell Biol Toxicol. 2023 Feb;39(1):165-182. doi: 10.1007/s10565-021-09630-z. Epub 2021 Jul 20.
8
miR-16 integrates signal pathways in myofibroblasts: determinant of cell fate necessary for fibrosis resolution.miR-16 整合肌成纤维细胞中的信号通路:纤维化消退所必需的决定细胞命运的因素。
Cell Death Dis. 2020 Aug 7;11(8):639. doi: 10.1038/s41419-020-02832-z.
9
MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.微小 RNA-27a 通过激活 Wnt/β-连环蛋白信号通路靶向 Sfrp1 诱导糖尿病肾病肾纤维化。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20192794.
10
Loureirin B inhibits the proliferation of hepatic stellate cells and the Wnt/β-catenin signaling pathway by regulating miR-148-3p.芫花素 B 通过调控 miR-148-3p 抑制肝星状细胞增殖及其 Wnt/β-catenin 信号通路。
Cell Mol Biol Lett. 2018 Aug 2;23:35. doi: 10.1186/s11658-018-0098-9. eCollection 2018.